Research guide

GHK-Cu research explained: copper, collagen and skin

Evidence checked 16 October 2026

GHK-Cu starts with a very small peptide: glycine, histidine and lysine, the three amino acids behind the initials GHK. (Maquart et al., 1988) GHK binds copper, forming the complex called GHK-Cu. (Maquart et al., 1988)

The interesting research connects that small molecule with collagen production and the material surrounding skin cells. (Maquart et al., 1988) (Wegrowski et al., 1992) This guide follows the evidence from laboratory findings to human cosmetic studies, without treating them as the same thing.

The short answer

The molecule: A three-amino-acid peptide bound to copper. (Maquart et al., 1988)
The research focus: Collagen production, other supporting molecules around cells and the behaviour of specific skin formulations. (Maquart et al., 1988) (Wegrowski et al., 1992) (Wang et al., 2026)
The useful distinction: A cell experiment, a finished cosmetic cream and an injectable preparation have different evidence and safety questions. (Mortazavi et al., Bioimpacts) (FDA safety information)

Why the copper part matters

GHK was isolated from human plasma, and the peptide has an affinity for copper ions. (Maquart et al., 1988) GHK-Cu is the resulting copper complex, whereas Pal-GHK is a different, chemically modified version of GHK. (Mortazavi et al., Bioimpacts)

When reading a study, check which molecule was actually tested. A result for GHK, GHK-Cu or Pal-GHK should not automatically be assigned to all three.

The collagen finding that started a research thread

In 1988, researchers reported that GHK-Cu increased collagen production in fibroblasts, connective-tissue cells grown in the laboratory. (Maquart et al., 1988) The effect was independent of changes in cell number, so the finding was not simply explained by having more cells in the dish. (Maquart et al., 1988)

A later experiment in human fibroblasts found increased production of some sugar-based support molecules in the material around cells. (Wegrowski et al., 1992) It did not find an increase in hyaluronic-acid production in that experiment. (Wegrowski et al., 1992)

Newer skin models add useful detail

A 2023 study examined GHK-Cu together with hyaluronic acid in human skin cells and skin tissue studied outside the body. (Jiang et al., 2023) The combination increased measurements of one type of collagen, called type IV, in those models. (Jiang et al., 2023)

That is a finding about a tested combination, not proof of the same result from GHK-Cu alone or visible improvement in people. (Jiang et al., 2023) The study's authors were affiliated with biotechnology companies, which is useful context when interpreting the work. (Jiang et al., 2023)

What a 2026 cosmetic study reported

A 2026 paper studied a cream combining GHK-Cu with a mixed-culture ferment extract. (Wang et al., 2026) Thirty participants completed its 56-day human study, which reported improvements from baseline in selected wrinkle, hydration and skin-barrier measurements. (Wang et al., 2026)

There was no placebo comparison group in the human study, and the cream contained both active ingredients. (Wang et al., 2026) The results therefore cannot isolate GHK-Cu's contribution or establish that it outperformed another cream. (Wang et al., 2026)

All authors were affiliated with a cosmetic-company research centre; they declared no conflicts and no outside funding. (Wang et al., 2026) The practical research lesson is to keep the complete formulation and study design attached to the finding.

Human findings depend on the setting

An earlier randomised study examined skin-care regimens with or without GHK-Cu after laser resurfacing, with 13 participants completing the study. (Miller et al., 2006) It found no significant between-group difference in objective wrinkle, overall skin-quality or redness-resolution measures, although patient satisfaction was higher in the GHK-Cu group. (Miller et al., 2006)

That does not erase the laboratory findings. It shows why a biological mechanism and a measured cosmetic benefit need separate tests.

The clear takeaway

GHK-Cu has a clear laboratory research story involving collagen and other supporting molecules around cells. (Maquart et al., 1988) (Wegrowski et al., 1992) Human cosmetic findings are more limited and depend on the formulation, study design and outcome measured. (Mortazavi et al., Bioimpacts) (Miller et al., 2006) (Wang et al., 2026)

Results from creams do not establish the safety of injectable GHK-Cu. (FDA safety information) For that route, the FDA specifically identifies limited human safety data and potential immune-reaction concerns related to peptide clumping and impurities. (FDA safety information) Keeping those categories separate lets the interesting skin research stand on its own merits.

Related guides: GHK-Cu vs GLOW · BPC-157 vs TB-500.

This guide explains published research, not recommendations for personal use. It provides no dosing, administration or combining instructions. Findings apply to the materials, formulations and settings studied; they do not establish the safety, quality or suitability of a separately supplied research-labelled product.